Lawmakers will soon get their first chance to grill a President Donald Trump appointee on the administration's views on competition, and practitioners will be closely watching for signs of the direction the U.S. Department of Justice would take on antitrust and merger enforcement under nominee Makan Delrahim.
Zimmer Holdings Inc., one of the orthopedic companies being investigated by the Justice Department for alleged price-fixing, divulged Wednesday specifics about the case that, if true, would ostensibly clear it of wrongdoing.
Federal prosecutors are taking aim at a deal involving the hotly-contested heart drug Plavix, launching a criminal investigation of a proposed settlement between Bristol-Myers Squibb Co., Sanofi-Aventis and Apotex Inc.
Visa USA, MasterCard Inc. and a number of banks have agreed to shell out $336 million to resolve consumer antitrust suits over charges for foreign transactions.
Publisher McClatchy Co. has asked a court to throw out an antitrust lawsuit aimed at preventing the company from selling three San Francisco Bay Area newspapers that it picked up after buying Knight Ridder Inc. this year.
The Department of Justice derided—before later lauding—a bill that would eliminate flight restrictions at Dallas Love Field airport on grounds that it would violate federal antitrust laws.
The Department of Justice can proceed in its claims against Stolt-Nielsen SA, after the U.S. Supreme Court refused to temporarily block the government from filing antitrust charges against the transport company.
Exhibits and testimony offered behind closed doors may soon be made public in the ongoing antitrust litigation between semiconductor maker Rambus and several other chip makers.
A missed deadline at an appeals court has cleared the way for Microsoft Corp. to pay out $1.1 billion in a class action antitrust suit that accused the software giant of price-gouging.
A top plaintiff’s firm is trying to take a bite out of Apple Computer Inc., filing a class action that alleges the computer maker is using “illegal tactics” to fend off the competition for its iPod player and online music and video store.
A judge postponed a decision Monday on the settlement of a hospital price-gouging lawsuit until September, potentially throwing a wrench in a financial deal affecting as many as 700,000 people.
The Federal Trade Commission and Department of Justice joined hands to argue against anti-competitive action in the real estate industry before the House Committee on Financial Services on Tuesday, while representatives from the private sector insisted that competition in real estate is alive and well.
Australia’s competition watchdog has blasted Australian telecommunications company Telstra Corp. for stalling negotiations for more than four months over its broadband plan and putting the telecommunications industry at risk.
Class actions against orthopedic device makers are piling up in the wake of revelations that the U.S. Department of Justice is investigating 75% of the orthopedic industry for alleged price-fixing. We take a look at what's ahead for the industry.
Taking a swipe at the United States over government subsidies to airlines, the E.U. trade chief complained Tuesday that the U.S. was trying to gain an unfair advantage for Boeing over France-based Airbus.
Although the review of two major telecom mergers is far from over, the judge presiding over the cases said Tuesday he would not yet require evidentiary hearings on the government’s approval of the deals.
Prominent World Trade Organization members called off talks for a global trade agreement Monday, citing unbridgeable differences over farm subsidies and import tariffs.
Amid the Federal Trade Commission’s probe of anti-competitive actions in the real estate industry, the House Financial Services Housing Subcommittee will hold a hearing Tuesday on business models in the industry.
In an effort to remove barriers between their economies, the competition watchdogs for Australia and New Zealand have agreed to join forces to examine mergers of companies that operate in both countries.
U.S. state attorneys general will rule on the second update of Bristol-Myers Squibb, Sanofi-Aventis and Apotex’s settlement agreement over the patent for generic Plavix within the next week.
A class action securities lawsuit alleging bid-rigging and price-fixing by insurance company Marsh & McLennan will head to court, after a judge ruled that the plaintiffs’ allegations warrant a jury trial.